How Will The Roadmap for Diagnostic Cardiology Devices Develop?
Published: July 4, 2022
30th June 2022 – Written by Kelly Patrick, Featured on HIT Consultant’s website
Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 pandemic saw global revenues for Resting ECG devices increase in 2020, whilst ECG Management Systems, Stress ECG and Traditional Holter ECG solutions saw a market decline. Country lockdowns resulted in reduced cardiology services during the peak of the pandemic, as non-urgent appointments were delayed. 2021 showed relief for cardiac facilities as providers started to deal with the patient backlog and demand returned for all solutions to above the levels seen in 2019.
Click here to continue reading on HIT Consultant’s website…Share on LinkedIn
Diagnostic CardiologyPublishing July 2023
This is a proposal for the interim update of our analysis on the global market for Diagnostic Cardiology, to be published in July 2023.
Find out more